AHR and Cowden disease: The fact that AhR content is reduced in mucosal cells (i.e., T cells), which are supposed to make a robust contribution to CD pathogenesis (1), and AhR triggers counter-regulatory effects in other systems (22, 28, 29), prompted us to explore the possibility that activation of AhR with exogenous ligands could dampen CD-associated inflammatory pathways.